CityBeat highlights CCM alum's impact on Price Hill arts scene

Eddy Kwon is a Cincinnati musician, composer and Price Hill Will artistic director

CityBeat featured CCM alumnus Eddy Kwon (BM Jazz Studies, 2011) and how the creative artist is staying resolved as COVID-19 upends their schedule. A composer-performer and community-based teaching artist, Kwon is "developing a growing reputation as one of the city's most exciting young creative individuals," writes Steve Rosen in the CityBeat story.

A violinist sings and performs on stage

Eddy Kwon. Photo/Kellie Coleman

Kwon serves as the Artistic Director of Price Hill Will, a non-profit comprehensive community development corporation. There Kwon oversees arts programs including: MyCincinnati, a tuition-free youth orchestra program; the annual Price Hill Creative Community Festival; the Creative Action Artist Residency; and a community-curated performance series. Many of Kwon's 2020 plans have had to change in response to the pandemic, but they (Kwon identifies as non-binary) are still keeping active with exciting projects. 

Price Hill Will is planning its fifth Creative Community Festival and is continuing its $10-million restoration of the Price Hill Masonic Lodge in East Price Hill, which will add two performance venues and an art gallery. Kwon is organizing a community curatorial collective to program the venues. As a composer-performer, Kwon is working on a music-art collaboration called Boy mother / faceless bloom, which is set to debut in 2021 at Colorado College and the Contemporary Arts Center. Kwon is also working on UMMA-YA, a solo performance piece that draws on Korean music tradition.

Read more about Kwon in CityBeat's story.

Related Stories

1

UC biologist talks about 'pearmageddon'

March 16, 2026

WLWT talks to UC biologist and Department Head Theresa Culley about invasive, nonnative Callery pear trees that are spreading across Ohio forests after they were introduced by landscapers more than 50 years ago.

3

Trial results support weekly buprenorphine treatment of opioid use disorder during pregnancy

March 16, 2026

Supported by the National Institutes of Health (NIH), researchers led by the University of Cincinnati's John Winhusen published clinical trial results in JAMA Internal Medicine that found administering weekly injectable extended-release buprenorphine for treatment of opioid use disorder during pregnancy led to higher rates of abstinence from illicit opioids than buprenorphine given daily under the tongue, one of the standard methods of treatment.